John de Kruif

Chief Tech/Sci/R&D Officer at MERUS N.V.

60 year

Health Technology

Consumer Services

John de Kruif active positions

Companies	Position	Start	End
MERUS N.V.	Chief Tech/Sci/R&D Officer	2007-03-31	-

Companies	Position	Start	End
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Corporate Officer/Principal	2000-09-30	2006-09-30

University of Utrecht

Doctorate Degree

International

Netherlands

Operational

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Doctorate Degree	1

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
MERUS N.V.	Health Technology

Private companies	1
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Health Technology

Private companies

Health Technology